It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Multidrug-resistant tuberculosis (MDR-TB) is an emerging public health problem in Nepal. Despite the implementation of a successful TB control program in Nepal, notifications of MDR-TB are increasing, yet the reasons are unknown. The objective of this study was to understand the genetic diversity and epidemiological characteristics of MDR-Mycobacterium tuberculosis (MTB) isolates in Nepal. We isolated and genotyped 498 MDR-MTB isolates collected from April 2009 to March 2013 and analyzed the patients’ background information. Our results showed that the lineage 2 (Beijing family) was the most predominant lineage (n = 241; 48.4%), followed by lineage 3 (n = 153, 30.7%). Lineage 4 was the third most prevalent (n = 73, 14.5%) followed by lineage 1 (n = 32, 6.4%). The lineages were significantly associated with geographic region, ethnic group, age and sex of patients. The Beijing genotype was found to have an important role in transmitting MDR-TB in Nepal and was significantly associated with the eastern region, mongoloid ethnic group and younger age group. We conclude that early diagnosis and treatment including molecular-epidemiological surveillance of MDR-TB cases will help to control transmission of MDR-TB in Nepal.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 German Nepal TB Project (GENETUP/NATA), Kathmandu, Nepal; Division of Bioresources, Hokkaido University, Research Center for Zoonosis Control, Hokkaido, Japan
2 Division of Bioresources, Hokkaido University, Research Center for Zoonosis Control, Hokkaido, Japan; Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Hokkaido, Japan
3 Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Hokkaido, Japan; Unit of Risk Analysis and Management, Research Center for Zoonosis Control, Hokkaido, Japan
4 Division of Bioresources, Hokkaido University, Research Center for Zoonosis Control, Hokkaido, Japan
5 Department of Microbiology, Chitwan Medical College Teaching Hospital, Chitwan, Nepal
6 German Nepal TB Project (GENETUP/NATA), Kathmandu, Nepal
7 WHO-Supranational Reference Laboratory of Tuberculosis, Gauting, Germany; KuratoriumTuberkulose in der Welt e.V, München-Gauting, Germany
8 KuratoriumTuberkulose in der Welt e.V, München-Gauting, Germany; Asklepios Klinik, Gauting, Germany
9 National Tuberculosis Center, Thimi, Bhaktapur, Nepal; World Health Organization, Kathmandu, Nepal
10 Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Hokkaido, Japan; UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland